IMCD NV (XAMS:IMCD) Valuation Rank


XAMS:IMCD IMCD NV XAMS:IMCD
87 GF Score
Price €80.20
GF Value €141.11
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is IMCD NV Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

IMCD NV Valuation Rank Related Terms

XAMS:IMCD
87GF Score
IMCD NV XAMS:IMCD
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IMCD NV (XAMS:IMCD) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of €80.20 is trading 43.2% below its estimated GF Value™ of €141.11. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for XAMS:IMCD:

  • Valuation Rank:
  • GF Value™: €141.11 vs. price of €80.20 (43.2% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the XAMS:IMCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
87GF Score

Get the complete analysis for XAMS:IMCD

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€80.20
Price
€141.11
GF Value